Delivery Order SPE2DR25D2206-SPE2DR26F9GP4
Award Date 12/18/25
Potential Completion Date 12/19/25
Potential Value $68K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $47,825.80 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count units) on November 28, 2025, with an ultimate completion date of December 1, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be...
- The Defense Logistics Agency awarded a $7,430.62 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit doses), with a completion date of December 2, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $7,509.61 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 10, 2025, and performance location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement. This delivery order...
- The Defense Logistics Agency awarded a $37,962.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (UU 28s) with an ultimate completion date of December 8, 2025. This non-set-aside award was issued on December 5, 2025, to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $21,799.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This competitively awarded, non-set-aside contract is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $10,854.26 to AmerisourceBergen Drug Corp for RINVOQ ER 45 mg tablets (28-count unit of use packaging) on December 9, 2025, with completion expected by December 10, 2025. This firm fixed-price delivery order is non-competitive and represents a single transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $18,350.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for RINVOQ ER 45 mg tablets (28-count units). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $45,284.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of RINVOQ ER 15 mg tablets (30-unit packages). This is a non-set-aside, competitively awarded contract with performance completion targeted for December 15, 2025, and fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $23,153.27 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor will perform this...